Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas

Endocrine

Volumn 46, Issue 3, 2014, Pages 526-531

  Kim, Ju Yeon ^a   Park, Taejin ^a   Jeong, Sang Ho ^a   Jeong, Chi Young ^a   Ju, Young Tae ^a   Lee, Young Joon ^a   Hong, Soon Chan ^a   Ha, Woo Song ^a   Choi, Sang Kyung ^a   Jung, Eun Jung ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Cancer; Neutrophil to lymphocyte ratio; Prognosis; Thyroid

Indexed keywords

ADVANCED CANCER; ARTICLE; BENIGN TUMOR; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; NEUTROPHIL TO LYMPHOCYTE RATIO; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SOLID TUMOR; THYROID CARCINOMA; THYROID CYST; THYROID NODULE; ADULT; DISEASE COURSE; IMMUNOLOGY; LEUKOCYTE COUNT; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; CARCINOMA, PAPILLARY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84904544391     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0089-6     Document Type: Article

References (39)

1. L.M. Coussens, Z. Werb, Inflammation and cancer. Nature 420(6917), 860-867 (2002). doi:10.1038/nature01322
2. T.L. Whiteside, The tumor microenvironment and its role in promoting tumor growth. Oncogene 27(45), 5904-5912 (2008). doi:10.1038/onc.2008.271
3. H. Nozawa, C. Chiu, D. Hanahan, Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl Acad. Sci. USA 103(33), 12493-12498 (2006). doi:10.1073/pnas.0601807103
4. D.C. McMillan, The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat. Rev. 39(5), 534-540 (2013). doi:10.1016/j.ctrv.2012.08.003
5. G.J. Guthrie, K.A. Charles, C.S. Roxburgh, P.G. Horgan, D.C. McMillan, S.J. Clarke, The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit. Rev. Oncol. Hematol. (2013). doi:10.1016/j.critrevonc.2013.03.010
6. H. Yu, X. Huang, X. Liu, H. Jin, G. Zhang, Q. Zhang, J. Yu, Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter. Endocrine 44(1), 172-181 (2013). doi:10.1007/s12020-012-9853-2
7. M.H. Rho, D.W. Kim, H.P. Hong, Y.M. Park, M.J. Kwon, S.J. Jung, Y.W. Kim, T. Kang, Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results. Endocrine 42(3), 647-653 (2012). doi:10.1007/s12020-012-9695-y
8. S.D. Larson, L.N. Jackson, T.S. Riall, T. Uchida, R.P. Thomas, S. Qiu, B.M. Evers, Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J. Am. Coll. Surg. 204(5), 764-773 (2007). doi:10.1016/j.jamcollsurg.2006.12.037. discussion 773-765
9. D.P. Bradly, V. Reddy, R.A. Prinz, P. Gattuso, Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 146(6), 1099-1104 (2009). doi:10.1016/j.surg.2009.09.025
10. Y. Lun, X. Wu, Q. Xia, Y. Han, X. Zhang, Z. Liu, F. Wang, Z. Duan, S. Xin, J. Zhang, Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol. Head Neck Surg. 148(3), 396-402 (2013). doi:10.1177/0194599812472426
11. J.S. Jeong, H.K. Kim, C.R. Lee, S. Park, J.H. Park, S.W. Kang, J.J. Jeong, K.H. Nam, W.Y. Chung, C.S. Park, Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. J. Korean Med. Sci. 27(8), 883-889 (2012). doi:10.3346/jkms.2012.27.8.883
12. P. Del Rio, S. Cataldo, L. Sommaruga, L. Concione, M.F. Arcuri, M. Sianesi, The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol. 33(1), 1-5 (2008)
13. E.Y. Kim, W.G. Kim, W.B. Kim, T.Y. Kim, J.M. Kim, J.S. Ryu, S.J. Hong, G. Gong, Y.K. Shong, Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin. Endocrinol. (Oxf) 71(4), 581-586 (2009). doi:10.1111/j.1365-2265.2009.03537.x
14. C.L. Liu, J.J. Lee, T.P. Liu, Y.C. Chang, Y.C. Hsu, S.P. Cheng, Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. J. Surg. Oncol. 107(5), 493-497 (2013). doi:10.1002/jso.23270
15. B.D. Edge SB, C.C. Compton, A.G. Frits, F.L. Greene, A. Trotti, AJCC cancer staging manual, 7th edn. (Springer, New York, 2010)
16. H. Ubukata, G. Motohashi, T. Tabuchi, H. Nagata, S. Konishi, T. Tabuchi, Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J. Surg. Oncol. 102(7), 742-747 (2010). doi:10.1002/jso.21725
17. M. Aizawa, N. Gotohda, S. Takahashi, M. Konishi, T. Kinoshita, Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer. World J. Surg. 35(12), 2717-2722 (2011). doi:10.1007/s00268-011-1269-2
18. M.R. Jung, Y.K. Park, O. Jeong, J.W. Seon, S.Y. Ryu, D.Y. Kim, Y.J. Kim, Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J. Surg. Oncol. 104(5), 504-510 (2011). doi:10.1002/jso.21986
19. R.Z. Sharaiha, K.J. Halazun, F. Mirza, J.L. Port, P.C. Lee, A.I. Neugut, N.K. Altorki, J.A. Abrams, Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann. Surg. Oncol. 18(12), 3362-3369 (2011). doi:10.1245/s10434-011-1754-8
20. M. Di Bari, F. Salvi, A.T. Roberts, D. Balzi, B. Lorenzetti, V. Morichi, L. Rossi, F. Lattanzio, N. Marchionni, Prognostic stratification of elderly patients in the emergency department: a comparison between the "Identification of Seniors at Risk" and the "Silver Code". J. Gerontol. A 67(5), 544-550 (2012). doi:10.1093/gerona/glr209
21. Y. Mohri, K. Tanaka, M. Ohi, T. Yokoe, C. Miki, M. Kusunoki, Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J. Surg. 34(2), 285-290 (2010). doi:10.1007/s00268-009-0302-1
22. H. Shimada, N. Takiguchi, O. Kainuma, H. Soda, A. Ikeda, A. Cho, A. Miyazaki, H. Gunji, H. Yamamoto, M. Nagata, High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13(3), 170-176 (2010). doi:10.1007/s10120-010-0554-3
23. I. Bhatti, O. Peacock, G. Lloyd, M. Larvin, R.I. Hall, Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am. J. Surg. 200(2), 197-203 (2010). doi:10.1016/j.amjsurg.2009.08.041
24. D.S. Wang, H.Y. Luo, M.Z. Qiu, Z.Q. Wang, D.S. Zhang, F.H. Wang, Y.H. Li, R.H. Xu, Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med. Oncol. 29(5), 3092-3100 (2012). doi:10.1007/s12032-012-0226-8
25. S.R. Walsh, E.J. Cook, F. Goulder, T.A. Justin, N.J. Keeling, Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J. Surg. Oncol. 91(3), 181-184 (2005). doi:10.1002/jso.20329
26. H.C. Kwon, S.H. Kim, S.Y. Oh, S. Lee, J.H. Lee, H.J. Choi, K.J. Park, M.S. Roh, S.G. Kim, H.J. Kim, J.H. Lee, Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 17(3), 216-222 (2012). doi:10.3109/1354750X.2012. 656705
27. T. Motomura, K. Shirabe, Y. Mano, J. Muto, T. Toshima, Y. Umemoto, T. Fukuhara, H. Uchiyama, T. Ikegami, T. Yoshizumi, Y. Soejima, Y. Maehara, Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J. Hepatol. 58(1), 58-64 (2013). doi:10.1016/j.jhep.2012.08.017
28. M. Tomita, T. Shimizu, T. Ayabe, A. Yonei, T. Onitsuka, Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res. 31(9), 2995-2998 (2011)
29. T. Gondo, J. Nakashima, Y. Ohno, O. Choichiro, Y. Horiguchi, K. Namiki, K. Yoshioka, M. Ohori, T. Hatano, M. Tachibana, Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 79(5), 1085-1091 (2012). doi:10.1016/j.urology.2011.11.070
30. S. Teramukai, T. Kitano, Y. Kishida, M. Kawahara, K. Kubota, K. Komuta, K. Minato, T. Mio, Y. Fujita, T. Yonei, K. Nakano, M. Tsuboi, K. Shibata, K. Furuse, M. Fukushima, Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur. J. Cancer 45(11), 1950-1958 (2009). doi:10.1016/j.ejca.2009.01.023
31. O.K. Idowu, Q. Ding, A.F. Taktak, C.R. Chandrasekar, Q. Yin, Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma. Biomarkers 17(6), 539-544 (2012). doi:10.3109/1354750X.2012.699554
32. H. Cho, H.W. Hur, S.W. Kim, S.H. Kim, J.H. Kim, Y.T. Kim, K. Lee, Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol. Immunother. 58(1), 15-23 (2009). doi:10.1007/s00262-008-0516-3
33. J.-D. Lin, C. Hsueh, T.-C. Chao, Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome. Thyroid 19(10), 1053-1059 (2009). doi:10.1089/thy.2009.0133
34. C. Seretis, S. Gourgiotis, G. Gemenetzis, F. Seretis, E. Lagoudianakis, G. Dimitrakopoulos, The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. Am. J. Surg. 205(6), 691-696 (2013). doi:10.1016/j.amjsurg.2012.08. 006
35. K. Pietras, A. Ostman, Hallmarks of cancer: interactions with the tumor stroma. Exp. Cell Res. 316 (8), 1324-1331 (2010). doi:10.1016/j.yexcr.2010.02. 045
36. C.S. Roxburgh, D.C. McMillan, Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 6(1), 149-163 (2010). doi:10.2217/fon.09.136
37. H.T. Petrie, L.W. Klassen, H.D. Kay, Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J. Immunol. 134(1), 230-234 (1985)
38. H.D. Kay, D.L. Smith, Regulation of human lymphocyte-mediated natural killer (NK) cell activity. I. Inhibition in vitro by peripheral blood granulocytes. J. Immunol. 130(1), 475-483 (1983)
39. H.Y. Shau, A. Kim, Suppression of lymphokine-activated killer induction by neutrophils. J. Immunol. 141(12), 4395-4402 (1988)